Acute Asthma Management
Immediately administer high-flow oxygen (40-60% via face mask) to maintain oxygen saturation >90% (>95% in pregnant patients or those with heart disease), nebulized albuterol 5 mg (or terbutaline 10 mg), and systemic corticosteroids (prednisolone 30-60 mg orally or hydrocortisone 200 mg IV) within the first 15-30 minutes of presentation. 1, 2
Initial Assessment and Severity Recognition
Assess severity objectively using peak expiratory flow (PEF) or FEV₁ measurements, as subjective clinical impression alone frequently underestimates severity—a critical and preventable cause of asthma deaths. 1, 2
Severe exacerbation features include: 3, 2
- Inability to complete sentences in one breath
- Respiratory rate >25 breaths/min
- Heart rate >110 beats/min
- PEF <50% of predicted or personal best
Life-threatening features requiring immediate ICU consideration include: 1, 2
- PEF <33% of predicted or personal best
- Silent chest, cyanosis, or feeble respiratory effort
- Bradycardia, hypotension, or altered mental status (confusion, drowsiness)
- Normal or elevated PaCO₂ (≥42 mmHg) in a breathless patient
- Severe hypoxia (PaO₂ <8 kPa or 60 mmHg)
Immediate Treatment Protocol (First Hour)
Oxygen Therapy
Administer 40-60% oxygen via face mask or nasal cannula to maintain SaO₂ >90% (>95% in pregnant patients or those with cardiac disease), and monitor continuously via pulse oximetry. 1, 2
Bronchodilator Therapy
Administer albuterol 2.5-5 mg via oxygen-driven nebulizer OR 4-8 puffs via metered-dose inhaler (MDI) with spacer every 20 minutes for 3 doses. 1, 2, 4 For children weighing <15 kg, use half doses (2.5 mg). 3 Nebulizer and MDI with spacer are equally effective when properly administered. 1
Systemic Corticosteroids - Critical Early Intervention
Give prednisolone 30-60 mg orally OR IV hydrocortisone 200 mg immediately—do not delay while "trying bronchodilators first." 1, 2, 5 Clinical benefits require a minimum of 6-12 hours to manifest. 5 Oral administration is as effective as intravenous and is preferred unless the patient cannot tolerate oral intake. 1
For children: prednisolone 1-2 mg/kg (maximum 40-60 mg). 3
Adjunctive Ipratropium Bromide
Add ipratropium bromide 0.5 mg to nebulized albuterol every 20 minutes for 3 doses, then as needed, for all moderate to severe exacerbations. 1, 2 This combination reduces hospitalizations, particularly in patients with severe airflow obstruction. 3, 1
Reassessment After Initial Treatment (15-30 Minutes)
Measure PEF or FEV₁ and assess clinical response including respiratory rate, heart rate, oxygen saturation, and ability to speak. 1, 2
If improving (PEF >50-75% predicted): 3
- Continue oxygen 40-60%
- Continue prednisolone 30-60 mg daily (or IV hydrocortisone 200 mg every 6 hours)
- Nebulized beta-agonist every 4-6 hours
If not improving after 15-30 minutes: 3, 2
- Continue oxygen and corticosteroids
- Increase nebulized beta-agonist frequency to every 15-30 minutes (up to continuous nebulization for severe cases)
- Continue ipratropium 0.5 mg every 4-6 hours
Escalation for Severe/Refractory Cases
Intravenous Magnesium Sulfate
Consider IV magnesium sulfate 2 g over 20 minutes for patients with severe exacerbations (PEF <40% predicted after initial treatment) or life-threatening features. 1, 2 This significantly increases lung function and decreases hospitalization necessity. 1
For children: 25-75 mg/kg (maximum 2 g) IV over 20 minutes. 1
Aminophylline (Use with Caution)
Consider IV aminophylline 250 mg over 20 minutes for severe refractory asthma, but never give as a bolus to patients already taking oral theophyllines. 3, 2 Monitor blood concentrations if continued for >24 hours. 3 Note that methylxanthines have increased side effects without superior efficacy compared to standard therapy. 1
Critical Pitfalls to Avoid
- Never administer sedatives of any kind to patients with acute asthma—this is absolutely contraindicated. 3, 1, 2
- Do not delay corticosteroid administration while "trying bronchodilators first"—steroids must be given immediately. 1
- Do not underestimate severity—always measure PEF or FEV₁ objectively, as subjective assessments are frequently inaccurate. 1, 2
- Avoid bolus aminophylline in patients already taking oral theophyllines. 3, 2
- Do not administer IV isoproterenol due to danger of myocardial toxicity. 1
Hospital Admission Criteria
Immediate hospital admission is required for: 3, 1
- Any life-threatening features present
- Features of severe attack persisting after initial treatment
- PEF <50% predicted after 1-2 hours of intensive treatment
- PEF <33% predicted at any time
Lower threshold for admission if: 3
- Presentation in afternoon/evening
- Recent nocturnal symptoms or hospital admission
- Previous severe attacks requiring intubation or ICU admission
- Poor social circumstances or inability to assess own condition
ICU Transfer Criteria
Transfer to ICU accompanied by a physician prepared to intubate if: 3, 1
- Deteriorating PEF despite treatment
- Worsening or persistent hypoxia or hypercapnia
- Exhaustion, feeble respirations, confusion, or drowsiness
- Silent chest with minimal air movement
- PaCO₂ ≥42 mmHg or rising
Discharge Criteria and Planning
Patients may be discharged when: 3, 1
- PEF ≥70% of predicted or personal best
- PEF diurnal variability <25%
- Symptoms minimal or absent
- Oxygen saturation stable on room air
- Patient stable for 30-60 minutes after last bronchodilator dose
- Continuation of oral prednisolone 30-60 mg daily for 5-10 days total (no taper needed for courses <10 days)
- Initiation or increase of inhaled corticosteroids at higher dosage than before admission
- Provision of peak flow meter and written self-management plan
- Verification of proper inhaler technique
- GP follow-up arranged within 1 week
- Respiratory clinic follow-up within 4 weeks
Special Considerations for Children
- Use half doses of bronchodilators (2.5 mg albuterol) for children weighing <15 kg 3
- Prednisolone dosing: 1-2 mg/kg (maximum 40-60 mg) 3
- Blood gas estimations are rarely helpful in deciding initial management in children 3
- Assessment in very young children may be difficult—presence of any severe features should heighten concern 3